vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and MONARCH CASINO & RESORT INC (MCRI). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $136.6M, roughly 1.5× MONARCH CASINO & RESORT INC). MONARCH CASINO & RESORT INC runs the higher net margin — 20.2% vs 8.3%, a 11.9% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 8.9%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 3.2%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

The Atlantis Casino Resort Spa is a hotel and casino located in Reno, Nevada, United States. It is owned and operated by Monarch Casino & Resort, Inc. Its three hotel towers have a combined 824 guest rooms and suites. The casino floor spans 64,814 sq ft. Often known simply as "Atlantis," it is one of Reno's most profitable and luxurious properties, competing directly with Peppermill Hotel Casino and Grand Sierra Resort for customers. Nearly $150 million has been spent on upgrading the facility.

COLL vs MCRI — Head-to-Head

Bigger by revenue
COLL
COLL
1.5× larger
COLL
$205.4M
$136.6M
MCRI
Growing faster (revenue YoY)
COLL
COLL
+4.0% gap
COLL
12.9%
8.9%
MCRI
Higher net margin
MCRI
MCRI
11.9% more per $
MCRI
20.2%
8.3%
COLL
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
3.2%
MCRI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COLL
COLL
MCRI
MCRI
Revenue
$205.4M
$136.6M
Net Profit
$17.0M
$27.6M
Gross Margin
62.5%
Operating Margin
29.6%
25.6%
Net Margin
8.3%
20.2%
Revenue YoY
12.9%
8.9%
Net Profit YoY
35.3%
38.9%
EPS (diluted)
$0.48
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
MCRI
MCRI
Q1 26
$136.6M
Q4 25
$205.4M
$140.0M
Q3 25
$209.4M
$142.8M
Q2 25
$188.0M
$136.9M
Q1 25
$177.8M
$125.4M
Q4 24
$181.9M
$134.5M
Q3 24
$159.3M
$137.9M
Q2 24
$145.3M
$128.1M
Net Profit
COLL
COLL
MCRI
MCRI
Q1 26
$27.6M
Q4 25
$17.0M
$22.9M
Q3 25
$31.5M
$31.6M
Q2 25
$12.0M
$27.0M
Q1 25
$2.4M
$19.9M
Q4 24
$12.5M
$4.2M
Q3 24
$9.3M
$27.6M
Q2 24
$19.6M
$22.7M
Gross Margin
COLL
COLL
MCRI
MCRI
Q1 26
Q4 25
62.5%
20.8%
Q3 25
61.7%
26.7%
Q2 25
57.7%
25.5%
Q1 25
54.8%
20.2%
Q4 24
54.0%
2.9%
Q3 24
60.8%
25.6%
Q2 24
62.5%
23.0%
Operating Margin
COLL
COLL
MCRI
MCRI
Q1 26
25.6%
Q4 25
29.6%
21.3%
Q3 25
29.7%
27.1%
Q2 25
18.7%
25.8%
Q1 25
12.2%
20.4%
Q4 24
20.9%
3.1%
Q3 24
21.9%
25.5%
Q2 24
32.7%
22.9%
Net Margin
COLL
COLL
MCRI
MCRI
Q1 26
20.2%
Q4 25
8.3%
16.4%
Q3 25
15.0%
22.1%
Q2 25
6.4%
19.7%
Q1 25
1.4%
15.8%
Q4 24
6.9%
3.1%
Q3 24
5.9%
20.0%
Q2 24
13.5%
17.7%
EPS (diluted)
COLL
COLL
MCRI
MCRI
Q1 26
$1.52
Q4 25
$0.48
$1.25
Q3 25
$0.84
$1.69
Q2 25
$0.34
$1.44
Q1 25
$0.07
$1.05
Q4 24
$0.36
$0.25
Q3 24
$0.27
$1.47
Q2 24
$0.52
$1.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
MCRI
MCRI
Cash + ST InvestmentsLiquidity on hand
$386.7M
$120.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$549.8M
Total Assets
$1.7B
$725.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
MCRI
MCRI
Q1 26
$120.1M
Q4 25
$386.7M
Q3 25
$285.9M
Q2 25
$222.2M
Q1 25
$197.8M
Q4 24
$162.8M
Q3 24
$120.0M
Q2 24
$271.6M
Stockholders' Equity
COLL
COLL
MCRI
MCRI
Q1 26
$549.8M
Q4 25
$301.7M
$537.7M
Q3 25
$274.8M
$558.4M
Q2 25
$232.2M
$539.2M
Q1 25
$234.4M
$535.6M
Q4 24
$228.8M
$517.7M
Q3 24
$234.3M
$513.3M
Q2 24
$216.6M
$498.4M
Total Assets
COLL
COLL
MCRI
MCRI
Q1 26
$725.2M
Q4 25
$1.7B
$712.8M
Q3 25
$1.6B
$725.4M
Q2 25
$1.6B
$705.8M
Q1 25
$1.6B
$712.1M
Q4 24
$1.7B
$691.6M
Q3 24
$1.6B
$671.1M
Q2 24
$1.1B
$672.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
MCRI
MCRI
Operating Cash FlowLast quarter
$123.0M
Free Cash FlowOCF − Capex
$122.4M
FCF MarginFCF / Revenue
59.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
MCRI
MCRI
Q1 26
Q4 25
$123.0M
$38.1M
Q3 25
$78.4M
$56.0M
Q2 25
$72.4M
$34.1M
Q1 25
$55.4M
$36.5M
Q4 24
$84.6M
$37.8M
Q3 24
$-9.0M
$40.3M
Q2 24
$67.4M
$24.3M
Free Cash Flow
COLL
COLL
MCRI
MCRI
Q1 26
Q4 25
$122.4M
$32.2M
Q3 25
$78.3M
$53.5M
Q2 25
$72.4M
$26.0M
Q1 25
$54.6M
$16.6M
Q4 24
$84.1M
$26.2M
Q3 24
$-9.2M
$35.4M
Q2 24
$67.1M
$11.0M
FCF Margin
COLL
COLL
MCRI
MCRI
Q1 26
Q4 25
59.6%
23.0%
Q3 25
37.4%
37.5%
Q2 25
38.5%
19.0%
Q1 25
30.7%
13.3%
Q4 24
46.2%
19.5%
Q3 24
-5.8%
25.7%
Q2 24
46.2%
8.5%
Capex Intensity
COLL
COLL
MCRI
MCRI
Q1 26
Q4 25
0.3%
4.2%
Q3 25
0.1%
1.7%
Q2 25
0.0%
5.9%
Q1 25
0.4%
15.8%
Q4 24
0.3%
8.6%
Q3 24
0.2%
3.6%
Q2 24
0.2%
10.4%
Cash Conversion
COLL
COLL
MCRI
MCRI
Q1 26
Q4 25
7.25×
1.66×
Q3 25
2.49×
1.77×
Q2 25
6.05×
1.26×
Q1 25
22.92×
1.84×
Q4 24
6.75×
8.98×
Q3 24
-0.96×
1.46×
Q2 24
3.44×
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

MCRI
MCRI

Casino$79.7M58%
Food and beverage$31.7M23%
Hotel$19.0M14%
Other$6.1M5%

Related Comparisons